Updated Jul 16, 2026
WEN LEANA has filed 4 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $244K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-01 | GKOS | GLAUKOS Corp | A — Grant or award | 1.9K | $0.00 | |
| 2026-05-04 | GKOS | GLAUKOS Corp | S — Open-market sale | 1.7K | $143.35 | $244K |
| 2026-01-08 | GKOS | GLAUKOS Corp | A — Grant or award | 623 | $0.00 | |
| 2025-01-02 | GKOS | GLAUKOS Corp | A — Grant or award | 2.1K | $0.00 | |
| 2025-01-02 | GKOS | GLAUKOS Corp | A — Grant or award | 461 | $0.00 |
WEN LEANA is a corporate insider — currently tracked as Director of UroGen Pharma Ltd. (URGN). InsiderAlpha tracks every SEC Form 4 filing in real time.
4 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($244K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live WEN LEANA profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.